MET-话题@MedSci

#MET#

1464篇内容 | 3084人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1896949, encodeId=862e1896949dd, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, objectType=article, longId=221045, objectId=9e8a22104543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8a22104543, replyNumber=0, likeNumber=100, createdTime=2022-05-25, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8a22104543, moduleTitle=Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8a22104543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896932, encodeId=1ad0189693293, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=50. Meta分析的目的是什么？, objectType=article, longId=220206, objectId=65c622020698, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65c622020698, replyNumber=0, likeNumber=72, createdTime=2021-11-23, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65c622020698, moduleTitle=50. Meta分析的目的是什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65c622020698)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896987, encodeId=605d189698eb3, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：布雷默诺肽对肥胖女性体重的影响, objectType=article, longId=299793, objectId=af41299e936d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af41299e936d, replyNumber=0, likeNumber=81, createdTime=2023-02-01, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af41299e936d, moduleTitle=Diabetes Obes Metab：布雷默诺肽对肥胖女性体重的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af41299e936d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896904, encodeId=340818969047e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Front Oncol：EGFR突变NSCLC患者EGFR-TKI治疗进展后MET扩增患者的不同治疗策略的疗效探索, objectType=article, longId=218122, objectId=df5c21812297, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df5c21812297, replyNumber=0, likeNumber=56, createdTime=2022-09-02, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df5c21812297, moduleTitle=Front Oncol：EGFR突变NSCLC患者EGFR-TKI治疗进展后MET扩增患者的不同治疗策略的疗效探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df5c21812297)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896887, encodeId=fa4b189688e12, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=IMR:乳癖散结胶囊治疗乳腺疼痛，一项系统评价和meta分析, objectType=article, longId=216589, objectId=b1da21658908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b1da21658908, replyNumber=0, likeNumber=56, createdTime=2022-07-15, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b1da21658908, moduleTitle=IMR:乳癖散结胶囊治疗乳腺疼痛，一项系统评价和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b1da21658908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1897005, encodeId=603a189e00563, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, objectType=article, longId=723990, objectId=9450e23990da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9450e23990da, replyNumber=0, likeNumber=30, createdTime=2022-04-13, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9450e23990da, moduleTitle=AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9450e23990da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896873, encodeId=2c5018968e37e, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Metabolism：伴有糖尿病/应激性高血糖的COVID-19肺炎患者血栓栓塞风险, objectType=article, longId=215445, objectId=2c0d21544590, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c0d21544590, replyNumber=0, likeNumber=66, createdTime=2022-03-20, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c0d21544590, moduleTitle=Metabolism：伴有糖尿病/应激性高血糖的COVID-19肺炎患者血栓栓塞风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c0d21544590)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896963, encodeId=895a189696330, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=J Clin Invest：MEK抑制剂 cobimetinib联合PD-L1抑制剂 atezolizumab可延长胆道癌(BTC)的PFS, objectType=article, longId=293561, objectId=cf2c293561b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf2c293561b4, replyNumber=0, likeNumber=68, createdTime=2022-10-04, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf2c293561b4, moduleTitle=J Clin Invest：MEK抑制剂 cobimetinib联合PD-L1抑制剂 atezolizumab可延长胆道癌(BTC)的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf2c293561b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896938, encodeId=d3f7189693810, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：根据基线糖化血红蛋白(HbA1c)亚组扩大度拉糖肽剂量范围的血糖疗效, objectType=article, longId=220009, objectId=8cbd220009c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cbd220009c6, replyNumber=0, likeNumber=70, createdTime=2022-08-16, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cbd220009c6, moduleTitle=Diabetes Obes Metab：根据基线糖化血红蛋白(HbA1c)亚组扩大度拉糖肽剂量范围的血糖疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cbd220009c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896981, encodeId=738b18969813d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系, objectType=article, longId=299295, objectId=a776299295b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a776299295b6, replyNumber=0, likeNumber=76, createdTime=2022-05-29, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a776299295b6, moduleTitle=Diabetes Obes Metab：恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a776299295b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1897011, encodeId=5178189e01143, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率, objectType=article, longId=724709, objectId=29b7e24709c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b7e24709c1, replyNumber=0, likeNumber=76, createdTime=2023-01-30, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b7e24709c1, moduleTitle=Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29b7e24709c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1897022, encodeId=bea6189e0223d, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=FDA批准非药物疗法NeuroMetrix治疗纤维肌痛，是一种创新神经调节医疗器械, objectType=article, longId=729774, objectId=849ee29774d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=849ee29774d3, replyNumber=0, likeNumber=85, createdTime=2022-07-26, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=849ee29774d3, moduleTitle=FDA批准非药物疗法NeuroMetrix治疗纤维肌痛，是一种创新神经调节医疗器械, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=849ee29774d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896867, encodeId=b2b3189686e51, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metabolism：旧药可新用！Cell子刊揭示糖皮质激素药物相关副作用的遗传位点, objectType=article, longId=214240, objectId=99b1214240b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99b1214240b6, replyNumber=0, likeNumber=86, createdTime=2021-12-16, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99b1214240b6, moduleTitle=Cell Metabolism：旧药可新用！Cell子刊揭示糖皮质激素药物相关副作用的遗传位点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99b1214240b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896879, encodeId=f40e18968e9f5, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Diabetes Obes Metab：与单用德谷胰岛素相比，IDegLira可以显著降低HbA1c、减轻体重及降低低血糖风险, objectType=article, longId=215855, objectId=007d215855a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007d215855a1, replyNumber=0, likeNumber=85, createdTime=2022-02-06, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007d215855a1, moduleTitle=Diabetes Obes Metab：与单用德谷胰岛素相比，IDegLira可以显著降低HbA1c、减轻体重及降低低血糖风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=007d215855a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896960, encodeId=744b189696024, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, objectType=article, longId=292783, objectId=80f3292e835e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80f3292e835e, replyNumber=0, likeNumber=106, createdTime=2022-10-23, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80f3292e835e, moduleTitle=Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80f3292e835e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896974, encodeId=b51818969e492, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Nutr Metab Cardiovasc Dis：STEMI患者直接PCI后体内维生素D与胆固醇水平的关系, objectType=article, longId=295207, objectId=295329520e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=295329520e26, replyNumber=0, likeNumber=88, createdTime=2022-03-04, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=295329520e26, moduleTitle=Nutr Metab Cardiovasc Dis：STEMI患者直接PCI后体内维生素D与胆固醇水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=295329520e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896957, encodeId=7b20189695e43, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=J Clin Endocrinol Metab：血压变异性与骨折风险研究, objectType=article, longId=292073, objectId=f8402920e318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8402920e318, replyNumber=0, likeNumber=86, createdTime=2022-04-20, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8402920e318, moduleTitle=J Clin Endocrinol Metab：血压变异性与骨折风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8402920e318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896975, encodeId=e33e18969e5e0, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效, objectType=article, longId=295362, objectId=66af295362ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66af295362ac, replyNumber=0, likeNumber=80, createdTime=2022-10-14, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66af295362ac, moduleTitle=Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66af295362ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896991, encodeId=2fdc189699194, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, objectType=article, longId=300540, objectId=a882300540f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a882300540f9, replyNumber=0, likeNumber=60, createdTime=2022-05-29, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a882300540f9, moduleTitle=Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a882300540f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1896945, encodeId=9b9b189694556, content=<a href='/topic/show?id=4a391158248' target=_blank style='color:#2F92EE;'>#MET#</a>, objectTitle=Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究, objectType=article, longId=220835, objectId=9070220835a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9070220835a6, replyNumber=0, likeNumber=71, createdTime=2022-10-08, rootId=0, userName=一闲, userId=18fc139, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9070220835a6, moduleTitle=Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9070220835a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

MET

2020-05-29

一闲 (审核中...)

前往app查看评论内容

#MET#

Nuclear-translocation of ACLY induced by obesity-related factors enhances pyrimidine metabolism through regulating histone acetylation in endometrial cancer

2022-05-25

一闲 (审核中...)

前往app查看评论内容

#MET#

50. Meta分析的目的是什么？

2021-11-23

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：布雷默诺肽对肥胖女性体重的影响

2023-02-01

一闲 (审核中...)

前往app查看评论内容

#MET#

Front Oncol：EGFR突变NSCLC患者EGFR-TKI治疗进展后MET扩增患者的不同治疗策略的疗效探索

2022-09-02

一闲 (审核中...)

前往app查看评论内容

#MET#

IMR:乳癖散结胶囊治疗乳腺疼痛，一项系统评价和meta分析

2022-07-15

一闲 (审核中...)

前往app查看评论内容

#MET#

AACR重磅之GLORY试验：SCC244对携带MET 14外显子跳变（METex14）的NSCLC患者的II期研究

2022-04-13

一闲 (审核中...)

前往app查看评论内容

#MET#

Metabolism：伴有糖尿病/应激性高血糖的COVID-19肺炎患者血栓栓塞风险

2022-03-20

一闲 (审核中...)

前往app查看评论内容

#MET#

J Clin Invest：MEK抑制剂 cobimetinib联合PD-L1抑制剂 atezolizumab可延长胆道癌(BTC)的PFS

2022-10-04

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：根据基线糖化血红蛋白(HbA1c)亚组扩大度拉糖肽剂量范围的血糖疗效

2022-08-16

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系

2022-05-29

一闲 (审核中...)

前往app查看评论内容

#MET#

Metabolism：新冠肺炎合并2型糖尿病患者入院前抗糖尿病药物的使用与死亡率

2023-01-30

一闲 (审核中...)

前往app查看评论内容

#MET#

FDA批准非药物疗法NeuroMetrix治疗纤维肌痛，是一种创新神经调节医疗器械

2022-07-26

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metabolism：旧药可新用！Cell子刊揭示糖皮质激素药物相关副作用的遗传位点

2021-12-16

一闲 (审核中...)

前往app查看评论内容

#MET#

Diabetes Obes Metab：与单用德谷胰岛素相比，IDegLira可以显著降低HbA1c、减轻体重及降低低血糖风险

2022-02-06

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metabol：别吃药了！在抗衰老和维持健康方面日常膳食明显优于药物！

2022-10-23

一闲 (审核中...)

前往app查看评论内容

#MET#

Nutr Metab Cardiovasc Dis：STEMI患者直接PCI后体内维生素D与胆固醇水平的关系

2022-03-04

一闲 (审核中...)

前往app查看评论内容

#MET#

J Clin Endocrinol Metab：血压变异性与骨折风险研究

2022-04-20

一闲 (审核中...)

前往app查看评论内容

#MET#

Ann Oncol：II期临床研究ROAR更新：Dabrafenib(达拉菲尼)联合trametinib(曲美替尼)治疗BRAF V600E突变间变性甲状腺癌的疗效

2022-10-14

一闲 (审核中...)

前往app查看评论内容

#MET#

Cell Metabolism：陈斯迪团队利用CRISPR筛选，发现增强CAR-T效果新手段

2022-05-29

一闲 (审核中...)

前往app查看评论内容

#MET#

Clin Cancer Res：Tepotinib治疗MET外显子14 (METex14)跳跃NSCLC患者的疗效和安全性：VISION研究

2022-10-08

科室
- - 订阅+
  - 更多科室
工具
服务